Top

Published in:

01-09-2019 | Chronic Heart Failure | Research Letter

Human heart shifts from IGF-1 production to utilization with chronic heart failure

Authors: Roberta D’Assante, Raffaele Napoli, Andrea Salzano, Carlotta Pozza, Alberto Maria Marra, Michele Arcopinto, Giuseppe Perruolo, Salvatore Milano, Pietro Formisano, Lavinia Saldamarco, Plinio Cirillo, Antonio Cittadini

Published in: Endocrine | Issue 3/2019

Excerpt

Chronic heart failure (CHF) is characterized by multiple hormonal and metabolic deficiencies (MHD) [1, 2]. In this context, abnormalities of growth hormone (GH) and its effector insulin like growth factor-1 (IGF-1) play a distinct and relevant role [3, 4]. Circulating levels of IGF-1 have been associated with cardiovascular events and mortality in CHF, but the benefit of the use of IGF-1 as prognostic marker in CHF is still unresolved [5]. Stimulation of IGF-1 receptors by the hormone can occur in response to the plasma circulating IGF-1 or to the local paracrine/autocrine production. Cardiomyocytes are able to produce IGF-1 mRNA and experimental conditions of heart hypertrophy are associated with an increase in such production, suggesting that modulation in local IGF-1 production might be an adaptive response to the need of local growth [6]. However, no data are available on the handling of IGF-1 by the human heart in vivo in healthy subjects or in patients with CHF. Thus, aim of the current study was to clarify whether human heart in vivo is an organ that generates or rather extracts IGF-1 and whether in patients with CHF there was a change in IGF-1 handling by the heart. For this purpose, we studied the difference in IGF-1 concentrations between aorta and coronary sinus in patients with or without CHF. In addition, we also evaluated inflammatory cytokine plasma glucose concentrations and their transcoronary concentration gradients (TCG). …

M. Arcopinto, A. Salzano, E. Bossone, F. Ferrara, E. Bobbio, D. Sirico, O. Vriz, C. De Vincentiis, M. Matarazzo, L. Saldamarco, F. Sacca, R. Napoli, M. Lacoviello, V. Triggiani, A.M. Isidori, C. Vigorito, J. Isgaard, A. Cittadini, Multiple hormone deficiencies in chronic heart failure. Int. J. Cardiol. 184, 421–423 (2015). https://doi.org/10.1016/j.ijcard.2015.02.055 CrossRefPubMed

A. Salzano, A.M. Marra, F. Ferrara, M. Arcopinto, E. Bobbio, P. Valente, R. Polizzi, C. De Vincentiis, M. Matarazzo, L. Saldamarco, F. Sacca, R. Napoli, M.G. Monti, R. D’Assante, A. Isidori, J. Isgaard, N. Ferrara, P.P. Filardi, F. Perticone, C. Vigorito, E. Bossone, A. Cittadini, T. Investigators, Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction. Int. J. Cardiol. 225, 1–3 (2016). https://doi.org/10.1016/j.ijcard.2016.09.085 CrossRefPubMed

Arcopinto M., Salzano A., Giallauria F., Bossone E., Isgaard J., Marra A. M., Bobbio E., Vriz O., Aberg D. N., Masarone D., De Paulis A., Saldamarco L., Vigorito C., Formisano P., Niola M., Perticone F., Bonaduce D., Sacca L., Colao A., Cittadini A., Scompen T. T. O. (2017) Growth Hormone Deficiency Is Associated with Worse Cardiac Function, Physical Performance, and Outcome in Chronic Heart Failure: Insights from the TOSCA. GHD Study. PLoS ONE 12 (1). https://doi.org/10.1371/journal.pone.0170058

M. Arcopinto, E. Bobbio, E. Bossone, P. Perrone-Filardi, R. Napoli, L. Sacca, A. Cittadini, The GH/IGF-1 Axis in Chronic Heart Failure. Endocr. Metab. Immune Disord.-Drug Targets 13(1), 76–91 (2013). https://doi.org/10.2174/1871530311313010010 CrossRefPubMed

M. Arcopinto, J. Isgaard, A.M. Marra, P. Formisano, E. Bossone, O. Vriz, C. Vigorito, L. Sacca, P.S. Douglas, A. Cittadini, IGF-1 predicts survival in chronic heart failure. Insights from the TOSCA. (Trattamento Ormonale Nello Scompenso CArdiaco) registry. Int. J. Cardiol. 176(3), 1006–1008 (2014). https://doi.org/10.1016/j.ijcard.2014.07.003 CrossRefPubMed

J. Isgaard, H. Wahlander, M.A. Adams, P. Friberg, Increased expression of growth-hormone receptor m-RNA and insulin-like growth-factor-I m-RNA in volume-overloaded hearts. Hypertension 23(6), 884–888 (1994). https://doi.org/10.1161/01.hyp.23.6.884 CrossRefPubMed

P. Ponikowski, A.A. Voors, S.D. Anker, H. Bueno, J.G.F. Cleland, A.J.S. Coats, V. Falk, J.R. Gonzalez-Juanatey, V.P. Harjola, E.A. Jankowska, M. Jessup, C. Linde, P. Nihoyannopoulos, J.T. Parissis, B. Pieske, J.P. Riley, G.M.C. Rosano, L.M. Ruilope, F. Ruschitzka, F.H. Rutten, P. van der Meer, G. Filippatos, J.J.V. McMurray, V. Aboyans, S. Achenbach, S. Agewall, N. Al-Attar, J.J. Atherton, J. Bauersachs, A.J. Camm, S. Carerj, C. Ceconi, A. Coca, P. Elliott, C. Erol, J. Ezekowitz, C. Fernandez-Golfin, D. Fitzsimons, M. Guazzi, 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 18(8), 891–975 (2016). https://doi.org/10.1002/ejhf.592 CrossRef

J. Niebauer, C.D. Pflaum, A.L. Clark, C.J. Strasburger, J. Hooper, P.A. Poole-Wilson, A.J.S. Coats, S.D. Anker, Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J. Am. Coll. Cardiol. 32(2), 393–397 (1998). https://doi.org/10.1016/s0735-1097(98)00226-5 CrossRefPubMed

M. Spies, O. Nesic, R.E. Barrow, J.R. Perez-Polo, D.N. Herndon, Liposomal IGF-1 gene transfer modulates pro- and anti-inflammatory cytokine mRNA expression in the burn wound. Gene Ther. 8(18), 1409–1415 (2001). https://doi.org/10.1038/sj.gt.3301543 CrossRefPubMed

10.

M. Arcopinto, A. Salzano, J. Isgaard, A. Cittadini, Hormone replacement therapy in heart failure. Curr. Opin. Cardiol. 30(3), 277–284 (2015). https://doi.org/10.1097/hco.0000000000000166 CrossRefPubMed

11.

E. Bossone, M. Arcopinto, M. Iacoviello, V. Triggiani, F. Cacciatore, C. Maiello, G. Limongelli, D. Masarone, F. Perticone, A. Sciacqua, P. Perrone-Filardi, A. Mancini, M. Volterrani, O. Vriz, R. Castello, A. Passantino, M. Campo, P.A. Modesti, A. De Giorgi, I. Monte, A. Puzzo, A. Ballotta, L. Caliendo, R. D’Assante, A.M. Marra, A. Salzano, T. Suzuki, A. Cittadini, T. Investigators, Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the TOSCA. Registry. Intern. Emerg. Med. 13(5), 661–671 (2018). https://doi.org/10.1007/s11739-018-1844-8 CrossRefPubMed

Title: Human heart shifts from IGF-1 production to utilization with chronic heart failure
Authors: Roberta D’Assante
Raffaele Napoli
Andrea Salzano
Carlotta Pozza
Alberto Maria Marra
Michele Arcopinto
Giuseppe Perruolo
Salvatore Milano
Pietro Formisano
Lavinia Saldamarco
Plinio Cirillo
Antonio Cittadini
Publication date: 01-09-2019
Publisher: Springer US
Keyword: Chronic Heart Failure
Published in: Endocrine / Issue 3/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-019-01993-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2019

Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways

Ethnic differences in body composition, sociodemographic characteristics and lifestyle in people with type 2 diabetes mellitus living in Italy

A review of the propriety of thyroid ultrasound referrals and their follow-up burden

Unusual metastases from differentiated thyroid carcinoma: analysis of 36 cases

Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas

Activation of retinal Müller cells in response to glucose variability

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials